Inventor · disambiguated record
Mark Laurence Boys
Also filed as: BOYS MARK L · BOYS MARK LAURENCE
28 granted patents·12 pending applications·81 citations·filing 1995–2025
95Inventor score
Top patents by PatentIndex Score
40 records- 0189US11802127B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Oct 31, 2023·1 cites·53 claims
- 0289US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0389US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0481US6531494B1Gem-substituted αvβ3 antagonistsPHARMACIA CORP·Filed 2001·Granted Mar 11, 2003·10 cites·15 claims
- 0580US9260450B2Therapeutic pyrazolyl thienopyridinesTHESAN PHARMACEUTICALS INC·Filed 2015·Granted Feb 16, 2016·2 cites·12 claims
- 0679US5840961AAsymmetric synthesis of chiral beta-amiNo acidsSEARLE & CO·Filed 1997·Granted Nov 24, 1998·27 cites·19 claims
- 0779US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0878US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 0978US7964612B2Therapeutic pyrazolyl thienopyridinesGRACEWAY PHARMACEUTICALS LLC·Filed 2007·Granted Jun 21, 2011·2 cites·12 claims
- 1077US8455512B2Therapeutic pyrazolyl thienopyridinesBARRETT STEPHEN D·Filed 2011·Granted Jun 4, 2013·4 cites·11 claims
- 1176US11691973B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Jul 4, 2023·0 cites·11 claims
- 1276US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1375US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 1475US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 1575US7119098B2Heteroarylakanoic acids as intergrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted Oct 10, 2006·8 cites·20 claims
- 1675US2024002384A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1774US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 1874US6933304B2Heteroarylalkanoic acids as integrin receptor antagonistsPHARMACIA CORP·Filed 2001·Granted Aug 23, 2005·8 cites·22 claims
- 1972US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 2071US2025263411A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2025·Application pending·0 cites
- 2170US2024124474A1Her2 mutation inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2267US11834453B2Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Dec 5, 2023·0 cites·28 claims
- 2367US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 2464US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 2563US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2662US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 2761US9090625B2Therapeutic pyrazolyl thienopyridinesTHESAN PHARMACEUTICALS INC·Filed 2013·Granted Jul 28, 2015·0 cites·18 claims
- 2858US7115596B2Thiazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Granted Oct 3, 2006·1 cites·6 claims
- 2957US9938289B2Therapeutic pyrazolyl thienopyridinesTHESAN PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·0 cites·17 claims
- 3057US2010048517A1Androgen modulatorsPFIZER·Filed 2009·Application pending·0 cites
- 3153US7670613B2Androgen modulatorsPFIZER·Filed 2005·Granted Mar 2, 2010·0 cites·12 claims
- 3247US2007225291A1Substituted Pyrazinone Compounds for the Treatment of InflammationPFIZER·Filed 2004·Application pending·0 cites
- 3346US5536869AProcess for the preparation of ethyl 3S-[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoateSEARLE & CO·Filed 1995·Granted Jul 16, 1996·3 cites·1 claims
- 3446US2004043994A1Gem-substituted alpha v beta 3 antagonistsFiled 2003·Application pending·0 cites
- 3544US2005004200A1Pyrazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3643US2005043344A1Heteroarylalkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3741US2014228349A15,7-substituted-imidazo[1,2-c]pyrimidinesARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3840US2009170886A1Androgen modulatorsPFIZER·Filed 2006·Application pending·0 cites
- 3936US5631399AProcess for the preparation of ethyl 3S-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoateSEARLE & CO·Filed 1996·Granted May 20, 1997·1 cites·1 claims
- 4034US8962596B25,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinasesBURGESS LAURENCE E·Filed 2011·Granted Feb 24, 2015·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →